Beatrolol
Cardiomyopathy
University of Sao PauloSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
9 Active assets in the Cardiomyopathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carvedilol Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | BB |
Deferiprone Ospedale Microcitemico | Phase 4 | BB |
Desferrioxamine B Ospedale Microcitemico | Phase 4 | BB |
Empagliflozin Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | BB |
Semaglutide Mayo Clinic | Phase 4 | BB |
View all 21 →
Same molecule, other indications
Beatrolol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →